Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cary O Harding

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
The American Journal of Clinical Nutrition|March 5, 2025
Phenylketonuria in adults: we know plenty, but there is much more to learnCary O Harding, Georgianne Arnold, Gerard T Berry, et al.
The Journal of Pediatrics|January 18, 2013
Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrateWendy Smith, George A Diaz, Uta Lichter-Konecki, et al.
Molecular Genetics and Metabolism|April 15, 2018
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)Janet Thomas, Harvey Levy, Stephen Amato, et al.
Clinical and Translational Science|May 31, 2021
Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuriaYulan Qi, Gina Patel, Joshua Henshaw, et al.
The Journal of Pediatrics|September 17, 2010
Prevalence and distribution of the c.1436C→T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infantsBradford D Gessner, Melanie B Gillingham, Monique A Johnson, et al.
Cell Transplantation|November 28, 2018
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1Raymond D Hickey, Clara T Nicolas, Kari Allen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2018
Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuriaNicola Longo, David Dimmock, Harvey Levy, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
Journal of Inherited Metabolic Disease|July 10, 2025
Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD)Hak Chung, Dongseok Choi, Ashley Gregor, et al.
Orphanet Journal of Rare Diseases|September 12, 2024
Meta-analysis of bone mineral density in adults with phenylketonuriaJúlio C Rocha, Álvaro Hermida, Cheryl J Jones, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The American Journal of Clinical Nutrition|March 5, 2025
Phenylketonuria in adults: we know plenty, but there is much more to learnCary O Harding, Georgianne Arnold, Gerard T Berry, et al.
The Journal of Pediatrics|January 18, 2013
Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrateWendy Smith, George A Diaz, Uta Lichter-Konecki, et al.
Molecular Genetics and Metabolism|April 15, 2018
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)Janet Thomas, Harvey Levy, Stephen Amato, et al.
Clinical and Translational Science|May 31, 2021
Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuriaYulan Qi, Gina Patel, Joshua Henshaw, et al.
The Journal of Pediatrics|September 17, 2010
Prevalence and distribution of the c.1436C→T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infantsBradford D Gessner, Melanie B Gillingham, Monique A Johnson, et al.
Cell Transplantation|November 28, 2018
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1Raymond D Hickey, Clara T Nicolas, Kari Allen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2018
Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuriaNicola Longo, David Dimmock, Harvey Levy, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
Journal of Inherited Metabolic Disease|July 10, 2025
Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD)Hak Chung, Dongseok Choi, Ashley Gregor, et al.
Orphanet Journal of Rare Diseases|September 12, 2024
Meta-analysis of bone mineral density in adults with phenylketonuriaJúlio C Rocha, Álvaro Hermida, Cheryl J Jones, et al.
Pageof 12